ArticleBMC cardiovascular disorders2026
Development and validation of a predictive model for side branch flow impairment following stent implantation in patients with non-left main coronary bifurcation lesions: a retrospective analysis.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectivesThe purpose of this study was to develop and validate a predictive model to assessing the risk of side branch flow impairment (SBFI) following stent implantation in patients with non-left main coronary bifurcation lesions (CBLs). This model aims to provide preprocedural risk stratification and inform the selection of interventional strategies.
backgroundCoronary artery bifurcation lesions constitute a particularly complex subtype of coronary artery disease that is frequently encountered in practice. Compared with non-bifurcation lesions, they are associated with greater procedural complexity and risk of procedure-related complications. PATIENTS AND
methodsData from 830 patients with CBL who underwent percutaneous coronary intervention (PCI) in the Affiliated Hospital of Chengde Medical University from January 2022 to December 2023 were retrospectively collected. The least absolute shrinkage and selection operator regression methods were used to screen variables, and multivariate logistic regression was used to establish a predictive model. A nomogram was built based on these factors and internally verified using the bootstrap resampling method. The C-statistic was used to verify and evaluate the discriminative ability of the model; the calibration curve was drawn, and the decision curve analysis (DCA) was performed to evaluate the calibration degree, clinical net benefit, and practicability of the model. The primary endpoint was SBFI, defined as a transient or persistent reduction in thrombolysis in myocardial infarction (TIMI) flow grade in a branch vessel following stent implantation in a major non-left main coronary artery.
resultsA nomogram was constructed using the selected predictors of SBFI, which included age, plaque location ipsilateral to the SB, TIMI flow grade before main vessel (MV) stenting, and N-terminal pro-brain natriuretic peptide (NT-proBNP). The discriminatory ability of the model, as assessed by the area under the curve (AUC), was 0.651. The robustness of the model was evaluated through internal validation with 1000 bootstrap replicates, resulting in a corrected AUC of 0.641. The calibration curve, evaluated by the Hosmer-Lemeshow test, showed good agreement between predictions and observations (χ
conclusionWe developed and validated a predictive model for SBFI after PCI in non-left main bifurcation lesions. The model exhibited modest discriminative ability, calibration, and a positive net benefit on DCA, suggesting that it may serve as a valuable risk stratification tool in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.